Olema Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Olema Pharmaceuticals, Inc. has filed 559 SEC EDGAR filings since 27 Aug 2018

SEC filing history

Showing 426-450 of 559 matching filings.

Per page
25
Current page
18
SC 13G File 005-91849

SC 13G

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91849

JANUS HENDERSON GROUP PLC OWNS >5%

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91849

SCHEDULE 13G

Filing date
10 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91849

SC 13G filing

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91849

SEC SCHEDULE 13G

Filing date
04 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Feb 2022
Reporting date
31 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jan 2022
Reporting date
10 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Dec 2021
Reporting date
10 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
14 Dec 2021
Reporting date
10 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
02 Dec 2021
Reporting date
30 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91849

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
02 Dec 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Dec 2021
Reporting date
29 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2021
Reporting date
10 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2021
Reporting date
19 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Oct 2021
Reporting date
14 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .